16-55479277-T-TGCG

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_004530.6(MMP2):​c.-183_-181dupCGG variant causes a 5 prime UTR change. The variant allele was found at a frequency of 0.0000722 in 401,388 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000056 ( 0 hom. )

Consequence

MMP2
NM_004530.6 5_prime_UTR

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.69

Publications

0 publications found
Variant links:
Genes affected
MMP2 (HGNC:7166): (matrix metallopeptidase 2) This gene is a member of the matrix metalloproteinase (MMP) gene family, that are zinc-dependent enzymes capable of cleaving components of the extracellular matrix and molecules involved in signal transduction. The protein encoded by this gene is a gelatinase A, type IV collagenase, that contains three fibronectin type II repeats in its catalytic site that allow binding of denatured type IV and V collagen and elastin. Unlike most MMP family members, activation of this protein can occur on the cell membrane. This enzyme can be activated extracellularly by proteases, or, intracellulary by its S-glutathiolation with no requirement for proteolytical removal of the pro-domain. This protein is thought to be involved in multiple pathways including roles in the nervous system, endometrial menstrual breakdown, regulation of vascularization, and metastasis. Mutations in this gene have been associated with Winchester syndrome and Nodulosis-Arthropathy-Osteolysis (NAO) syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
MMP2 Gene-Disease associations (from GenCC):
  • multicentric osteolysis, nodulosis, and arthropathy
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • multicentric osteolysis-nodulosis-arthropathy spectrum
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MMP2NM_004530.6 linkc.-183_-181dupCGG 5_prime_UTR_variant Exon 1 of 13 ENST00000219070.9 NP_004521.1 P08253-1A0A024R6R4
MMP2NM_001302508.1 linkc.-76+332_-76+334dupCGG intron_variant Intron 1 of 12 NP_001289437.1 P08253-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MMP2ENST00000219070.9 linkc.-183_-181dupCGG 5_prime_UTR_variant Exon 1 of 13 1 NM_004530.6 ENSP00000219070.4 P08253-1
MMP2ENST00000570308.5 linkc.-75-3612_-75-3610dupCGG intron_variant Intron 2 of 13 1 ENSP00000461421.1 P08253-2
MMP2ENST00000568715.5 linkc.-76+332_-76+334dupCGG intron_variant Intron 1 of 3 4 ENSP00000457949.1 H3BV48

Frequencies

GnomAD3 genomes
AF:
0.0000992
AC:
15
AN:
151274
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000970
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000389
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000738
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000560
AC:
14
AN:
250018
Hom.:
0
Cov.:
4
AF XY:
0.0000630
AC XY:
8
AN XY:
126950
show subpopulations
African (AFR)
AF:
0.000171
AC:
1
AN:
5860
American (AMR)
AF:
0.000191
AC:
1
AN:
5234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
6518
East Asian (EAS)
AF:
0.0000614
AC:
1
AN:
16292
South Asian (SAS)
AF:
0.000243
AC:
1
AN:
4122
European-Finnish (FIN)
AF:
0.0000576
AC:
1
AN:
17358
Middle Eastern (MID)
AF:
0.000924
AC:
1
AN:
1082
European-Non Finnish (NFE)
AF:
0.0000445
AC:
8
AN:
179686
Other (OTH)
AF:
0.00
AC:
0
AN:
13866
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.418
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000991
AC:
15
AN:
151370
Hom.:
0
Cov.:
32
AF XY:
0.000122
AC XY:
9
AN XY:
73976
show subpopulations
African (AFR)
AF:
0.0000967
AC:
4
AN:
41362
American (AMR)
AF:
0.000197
AC:
3
AN:
15220
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.000391
AC:
2
AN:
5118
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4802
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000738
AC:
5
AN:
67724
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000121

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Multicentric Osteolysis-Nodulosis-Arthropathy (MONA) Spectrum Disorders Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.7

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs567092201; hg19: chr16-55513189; API